These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35065331)

  • 1. Intracellular Co-delivery of native antibody and siRNA for combination therapy by using biodegradable silica nanocapsules.
    Yuan P; Yang F; Liew SS; Yan J; Dong X; Wang J; Du S; Mao X; Gao L; Yao SQ
    Biomaterials; 2022 Feb; 281():121376. PubMed ID: 35065331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-Targeting, Intracellular Delivery of Native Proteins Using Biodegradable Silica Nanoparticles.
    Yuan P; Mao X; Wu X; Liew SS; Li L; Yao SQ
    Angew Chem Int Ed Engl; 2019 Jun; 58(23):7657-7661. PubMed ID: 30994955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-Responsive Molecularly Imprinted Nanoparticles for Targeted Intracellular Delivery of Protein toward Cancer Therapy.
    Lu H; Xu S; Guo Z; Zhao M; Liu Z
    ACS Nano; 2021 Nov; 15(11):18214-18225. PubMed ID: 34664930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
    Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible pore-structure evolution in hollow silica nanocapsules: large pores for siRNA delivery and nanoparticle collecting.
    Chen Y; Chu C; Zhou Y; Ru Y; Chen H; Chen F; He Q; Zhang Y; Zhang L; Shi J
    Small; 2011 Oct; 7(20):2935-44. PubMed ID: 21901827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanosac, a Noncationic and Soft Polyphenol Nanocapsule, Enables Systemic Delivery of siRNA to Solid Tumors.
    Kim H; Yuk SA; Dieterly AM; Kwon S; Park J; Meng F; Gadalla HH; Cadena MJ; Lyle LT; Yeo Y
    ACS Nano; 2021 Mar; 15(3):4576-4593. PubMed ID: 33645963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect.
    Chen M; Wang L; Wang F; Li F; Xia W; Gu H; Chen Y
    Int J Nanomedicine; 2019; 14():3557-3569. PubMed ID: 31190812
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular Delivery of Functional Native Antibodies under Hypoxic Conditions by Using a Biodegradable Silica Nanoquencher.
    Yuan P; Zhang H; Qian L; Mao X; Du S; Yu C; Peng B; Yao SQ
    Angew Chem Int Ed Engl; 2017 Oct; 56(41):12481-12485. PubMed ID: 28816384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.
    Sun H; Yarovoy I; Capeling M; Cheng C
    Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery.
    Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A
    Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect
    Li F; Wang Y; Chen WL; Wang DD; Zhou YJ; You BG; Liu Y; Qu CX; Yang SD; Chen MT; Zhang XN
    Theranostics; 2019; 9(20):5886-5898. PubMed ID: 31534526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photo-tearable tape close-wrapped upconversion nanocapsules for near-infrared modulated efficient siRNA delivery and therapy.
    Zhang Y; Ren K; Zhang X; Chao Z; Yang Y; Ye D; Dai Z; Liu Y; Ju H
    Biomaterials; 2018 May; 163():55-66. PubMed ID: 29452948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.
    Resnier P; LeQuinio P; Lautram N; André E; Gaillard C; Bastiat G; Benoit JP; Passirani C
    Biotechnol J; 2014 Nov; 9(11):1389-401. PubMed ID: 25262914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
    Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
    Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy.
    Xu Z; Liu S; Kang Y; Wang M
    Nanoscale; 2015 Mar; 7(13):5859-68. PubMed ID: 25757484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
    Yuan Y; Liu J; Yu X; Liu X; Cheng Y; Zhou C; Li M; Shi L; Deng Y; Liu H; Wang G; Wang L; Wang Z
    Acta Biomater; 2021 Nov; 135():556-566. PubMed ID: 34496281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
    Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
    Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.